2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine

C238H222N26O2S2 — CID 158563731

About 2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine

2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine (PubChem CID 158563731) has the molecular formula C238H222N26O2S2 and a molecular weight of 3542.71 g/mol. Its IUPAC name is 2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine.

Molecular Properties

• Compound Name: 2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine
• PubChem CID: 158563731
• Molecular Formula: C238H222N26O2S2
• Molecular Weight: 3542.71 g/mol
• Exact Mass: 3539.75
• IUPAC Name: 2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine
• SMILES: CC1(C)COC(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NC(C)(C)CO5)nc4)c4c3ccc3ccccc34)cn2)=N1.CC1(C)CSC(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NC(C)(C)CS5)nc4)c4c3ccc3ccccc34)cn2)=N1.CC1(C)N=C(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NC(C)(C)C(C)(C)N5c5ccccc5)nc4)c4c3ccc3ccccc34)cn2)N(c2ccccc2)C1(C)C.CC1(C)c2ccccc2-c2c1ccc1c(-c3ccc(C4=NC(C)(C)C(C)(C)N4c4ccccc4)nc3)c3ccccc3c(-c3ccc(C4=NC(C)(C)C(C)(C)N4c4ccccc4)nc3)c21.CC1=NC(C)(C)C(C)(C)N1c1ccc(-c2c3ccccc3c(-c3ccc(N4C(C)=NC(C)(C)C4(C)C)nc3)c3c4c(ccc23)C(C)(C)c2ccccc2-4)cn1
• InChI: InChI=1S/C59H56N6.C54H50N6.C49H52N6.C38H32N4O2.C38H32N4S2/c1-55(2)45-28-20-19-27-43(45)51-46(55)32-31-44-49(37-29-33-47(60-35-37)53-62-56(3,4)58(7,8)64(53)39-21-13-11-14-22-39)41-25-17-18-26-42(41)50(52(44)51)38-30-34-48(61-36-38)54-63-57(5,6)59(9,10)65(54)40-23-15-12-16-24-40;1-51(2)53(5,6)59(38-20-11-9-12-21-38)49(57-51)44-31-28-36(33-55-44)46-41-25-17-18-26-42(41)47(48-40-24-16-15-19-35(40)27-30-43(46)48)37-29-32-45(56-34-37)50-58-52(3,4)54(7,8)60(50)39-22-13-10-14-23-39;1-29-52-46(5,6)48(9,10)54(29)39-25-21-31(27-50-39)41-33-17-13-14-18-34(33)42(32-22-26-40(51-28-32)55-30(2)53-47(7,8)49(55,11)12)44-36(41)23-24-38-43(44)35-19-15-16-20-37(35)45(38,3)4;2*1-37(2)21-43-35(41-37)30-17-14-24(19-39-30)32-27-11-7-8-12-28(27)33(34-26-10-6-5-9-23(26)13-16-29(32)34)25-15-18-31(40-20-25)36-42-38(3,4)22-44-36/h11-36H,1-10H3;9-34H,1-8H3;13-28H,1-12H3;2*5-20H,21-22H2,1-4H3
• InChIKey: HRFBGQIQCVFVAA-UHFFFAOYSA-N
• XLogP: 57.20
• TPSA: 290.40 Ų
• H-Bond Acceptors: 30
• Rotatable Bonds: 24
• Heavy Atoms: 268
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3542.71
LogP ≤ 5	57.20
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	30

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine?

The IUPAC name of 2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine (CID 158563731) is 2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine.

What is the SMILES notation for 2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine?

The canonical SMILES for 2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine is CC1(C)COC(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NC(C)(C)CO5)nc4)c4c3ccc3ccccc34)cn2)=N1.CC1(C)CSC(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NC(C)(C)CS5)nc4)c4c3ccc3ccccc34)cn2)=N1.CC1(C)N=C(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NC(C)(C)C(C)(C)N5c5ccccc5)nc4)c4c3ccc3ccccc34)cn2)N(c2ccccc2)C1(C)C.CC1(C)c2ccccc2-c2c1ccc1c(-c3ccc(C4=NC(C)(C)C(C)(C)N4c4ccccc4)nc3)c3ccccc3c(-c3ccc(C4=NC(C)(C)C(C)(C)N4c4ccccc4)nc3)c21.CC1=NC(C)(C)C(C)(C)N1c1ccc(-c2c3ccccc3c(-c3ccc(N4C(C)=NC(C)(C)C4(C)C)nc3)c3c4c(ccc23)C(C)(C)c2ccccc2-4)cn1.

What is the InChIKey of 2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine?

The InChIKey is HRFBGQIQCVFVAA-UHFFFAOYSA-N. The full InChI is InChI=1S/C59H56N6.C54H50N6.C49H52N6.C38H32N4O2.C38H32N4S2/c1-55(2)45-28-20-19-27-43(45)51-46(55)32-31-44-49(37-29-33-47(60-35-37)53-62-56(3,4)58(7,8)64(53)39-21-13-11-14-22-39)41-25-17-18-26-42(41)50(52(44)51)38-30-34-48(61-36-38)54-63-57(5,6)59(9,10)65(54)40-23-15-12-16-24-40;1-51(2)53(5,6)59(38-20-11-9-12-21-38)49(57-51)44-31-28-36(33-55-44)46-41-25-17-18-26-42(41)47(48-40-24-16-15-19-35(40)27-30-43(46)48)37-29-32-45(56-34-37)50-58-52(3,4)54(7,8)60(50)39-22-13-10-14-23-39;1-29-52-46(5,6)48(9,10)54(29)39-25-21-31(27-50-39)41-33-17-13-14-18-34(33)42(32-22-26-40(51-28-32)55-30(2)53-47(7,8)49(55,11)12)44-36(41)23-24-38-43(44)35-19-15-16-20-37(35)45(38,3)4;2*1-37(2)21-43-35(41-37)30-17-14-24(19-39-30)32-27-11-7-8-12-28(27)33(34-26-10-6-5-9-23(26)13-16-29(32)34)25-15-18-31(40-20-25)36-42-38(3,4)22-44-36/h11-36H,1-10H3;9-34H,1-8H3;13-28H,1-12H3;2*5-20H,21-22H2,1-4H3.

What are the key properties of 2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine?

2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine has a molecular weight of 3542.71 g/mol, XLogP of 57.20, 24 rotatable bonds, 0 hydrogen bond donors, and 30 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[5-[7-[6-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-oxazole;5-[8,8-dimethyl-5-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(2,4,4,5,5-pentamethylimidazol-1-yl)pyridine;5-[8,8-dimethyl-5-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]indeno[1,2-a]anthracen-13-yl]-2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)pyridine;2-[5-[7-[6-(4,4-dimethyl-5H-1,3-thiazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]-2-pyridinyl]-4,4-dimethyl-5H-1,3-thiazole;2-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-5-[7-[6-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)-3-pyridinyl]benzo[a]anthracen-12-yl]pyridine is sourced from PubChem (CID 158563731), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).